Understanding empirical therapeutics in systemic sclerosis gastrointestinal tract disease
Rheumatology (Oxford)
.
2017 Feb;56(2):176-177.
doi: 10.1093/rheumatology/kew322.
Epub 2016 Sep 27.
Author
Tracy M Frech
1
Affiliation
1
Internal Medicine, University of Utah, Salt Lake City, UT, USA tracy.frech@hsc.utah.edu.
PMID:
27677536
DOI:
10.1093/rheumatology/kew322
No abstract available
Publication types
Editorial
Comment
MeSH terms
Gastrointestinal Diseases*
Humans
Scleroderma, Localized
Scleroderma, Systemic*
Grants and funding
I01 CX001183/CX/CSRD VA/United States
K23 AR067889/AR/NIAMS NIH HHS/United States